These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19407122)

  • 1. Assessing transmission of lymphatic filariasis using parasitologic, serologic, and entomologic tools after mass drug administration in American Samoa.
    Mladonicky JM; King JD; Liang JL; Chambers E; Pa'au M; Schmaedick MA; Burkot TR; Bradley M; Lammie PJ
    Am J Trop Med Hyg; 2009 May; 80(5):769-73. PubMed ID: 19407122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of five annual rounds of mass drug administration with diethylcarbamazine and albendazole on Wuchereria bancrofti infection in American Samoa.
    Liang JL; King JD; Ichimori K; Handzel T; Pa'au M; Lammie PJ
    Am J Trop Med Hyg; 2008 Jun; 78(6):924-8. PubMed ID: 18541771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration.
    Lau CL; Sheridan S; Ryan S; Roineau M; Andreosso A; Fuimaono S; Tufa J; Graves PM
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005914. PubMed ID: 28922418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass treatment to eliminate filariasis in Papua New Guinea.
    Bockarie MJ; Tisch DJ; Kastens W; Alexander ND; Dimber Z; Bockarie F; Ibam E; Alpers MP; Kazura JW
    N Engl J Med; 2002 Dec; 347(23):1841-8. PubMed ID: 12466508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016.
    Sheel M; Sheridan S; Gass K; Won K; Fuimaono S; Kirk M; Gonzales A; Hedtke SM; Graves PM; Lau CL
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006583. PubMed ID: 30011276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa.
    Won KY; Robinson K; Hamlin KL; Tufa J; Seespesara M; Wiegand RE; Gass K; Kubofcik J; Nutman TB; Lammie PJ; Fuimaono S
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006347. PubMed ID: 29522520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.
    Ramaiah KD; Das PK; Vanamail P; Pani SP
    Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):555-63. PubMed ID: 17374389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine.
    Ramaiah KD; Vanamail P; Das PK
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):250-5. PubMed ID: 16890256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].
    Chanteau S; Roux JF
    Bull Soc Pathol Exot; 2008 Jun; 101(3):254-60. PubMed ID: 18681220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Border and imported bancroftian filariases: baseline seroprevalence in sentinel populations exposed to infections with Wuchereria bancrofti and concomitant HIV at the start of diethylcarbamazine mass treatment in Thailand.
    Bhumiratana A; Koyadun S; Srisuphanunt M; Satitvipawee P; Limpairojn N; Gaewchaiyo G
    Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):390-407. PubMed ID: 15916046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ongoing transmission of lymphatic filariasis in Samoa 4.5 years after one round of triple-drug mass drug administration.
    Mayfield HJ; Sartorius B; Sheridan S; Howlett M; Martin BM; Thomsen R; Tofaeono-Pifeleti R; Viali S; Graves PM; Lau CL
    PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012236. PubMed ID: 38935622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving community participation to eliminate lymphatic filariasis in American Samoa.
    King JD; Zielinski-Gutierrez E; Pa'au M; Lammie P
    Acta Trop; 2011 Sep; 120 Suppl 1():S48-54. PubMed ID: 20932818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
    Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
    Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame.
    Lau CL; Won KY; Lammie PJ; Graves PM
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005108. PubMed ID: 27802280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence and spatial epidemiology of Lymphatic Filariasis in American Samoa after successful mass drug administration.
    Lau CL; Won KY; Becker L; Soares Magalhaes RJ; Fuimaono S; Melrose W; Lammie PJ; Graves PM
    PLoS Negl Trop Dis; 2014; 8(11):e3297. PubMed ID: 25393716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards eliminating lymphatic filariasis in Papua New Guinea: impact of annual single-dose mass treatment on transmission of Wuchereria bancrofti in East Sepik Province.
    Bockarie MJ; Ibam E; Alexander ND; Hyun P; Dimber Z; Bockarie F; Alpers MP; Kazura JW
    P N G Med J; 2000; 43(3-4):172-82. PubMed ID: 11939298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti.
    Boyd A; Won KY; McClintock SK; Donovan CV; Laney SJ; Williams SA; Pilotte N; Streit TG; Beau de Rochars MV; Lammie PJ
    PLoS Negl Trop Dis; 2010 Mar; 4(3):e640. PubMed ID: 20351776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.
    Ramzy RM; El Setouhy M; Helmy H; Ahmed ES; Abd Elaziz KM; Farid HA; Shannon WD; Weil GJ
    Lancet; 2006 Mar; 367(9515):992-9. PubMed ID: 16564361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs.
    De Rochars MB; Direny AN; Roberts JM; Addiss DG; Radday J; Beach MJ; Streit TG; Dardith D; Lafontant JG; Lammie PJ
    Am J Trop Med Hyg; 2004 Oct; 71(4):466-70. PubMed ID: 15516644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographic, socioeconomic and disease knowledge factors, but not population mobility, associated with lymphatic filariasis infection in adult workers in American Samoa in 2014.
    Graves PM; Sheridan S; Fuimaono S; Lau CL
    Parasit Vectors; 2020 Mar; 13(1):125. PubMed ID: 32164780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.